Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies-Reference-Cited by-同舟云学术

Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies

Published:2011-08 Issue:8 Volume:63 Page:2456-2464
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Le Pavec Jérôme,Girgis Reda E.,Lechtzin Noah,Mathai Stephen C.,Launay David,Hummers Laura K.,Zaiman Ari,Sitbon Olivier,Simonneau Gérald,Humbert Marc,Hassoun Paul M.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference43 articles.

1. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis;Jimenez;Ann Intern Med,2004

2. Changes in causes of death in systemic sclerosis, 1972-2002;Steen;Ann Rheum Dis,2007

3. Treatment of pulmonary arterial hypertension;Humbert;N Engl J Med,2004

4. Systemic sclerosis-associated pulmonary arterial hypertension;Le Pavec;Am J Respir Crit Care Med,2010

5. Scleroderma patients with combined pulmonary hypertension and interstitial lung disease;Chang;J Rheumatol,2003

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registry;The Journal of Heart and Lung Transplantation;2024-10

2. Transplantation, bridging, and support technologies in pulmonary hypertension;European Respiratory Journal;2024-08-29

3. Intensive Care Unit Management of Right Heart Failure and Lung Transplantation for Pulmonary Hypertension;Current Respiratory Medicine Reviews;2024-08

4. Pulmonary Hypertension in Interstitial Lung Disease;CHEST;2024-05

5. Managing Pulmonary Arterial Hypertension With Cardiopulmonary Comorbidities;CHEST;2024-03